News
Ironwood Pharmaceuticals Announces Results From Phase 2 Exploratory STARGAZE Trial of Apraglutide For Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
28 Mar 24
Biotech, News, Health Care, General
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
7 Mar 24
Long Ideas, News, Penny Stocks, Health Care, Small Cap, Pre-Market Outlook, Markets, Trading Ideas, General
Wells Fargo Maintains Overweight on Ironwood Pharmaceuticals, Lowers Price Target to $14
1 Mar 24
News, Price Target, Analyst Ratings
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
29 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's Intraday Session
29 Feb 24
Movers
Why Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday?
29 Feb 24
Biotech, News, Health Care, Movers, Trading Ideas, General
Nasdaq Gains 100 Points Following PCE Data
29 Feb 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
29 Feb 24
Equities, Large Cap, Macro Economic Events, Mid Cap, Broad U.S. Equity ETFs, Currency ETFs, Small Cap, Econ #s, Top Stories, Economics, Federal Reserve, Pre-Market Outlook, Markets, Tech, ETFs
Ironwood Pharmaceuticals Announced Topline Results From Its Pivotal Phase 3 STARS Trial Of Once-weekly Subcutaneous Apraglutide In Reducing Parenteral Support Dependency In Adult Patients With Short Bowel Syndrome With Intestinal Failure
29 Feb 24
Biotech, News, Health Care, General
Top 4 Health Care Stocks You May Want To Dump In February
15 Feb 24
News, Penny Stocks, Short Ideas, Small Cap, Pre-Market Outlook, Markets, Trading Ideas
Ironwood Pharmaceuticals Q4 Sales $117.55M Beat $117.48M Estimate, Generated $35.8M In Cash From Operations In Q4
15 Feb 24
Earnings, News
Earnings Scheduled For February 15, 2024
15 Feb 24
Earnings
A Preview Of Ironwood Pharmaceuticals's Earnings
14 Feb 24
Earnings
Press releases
Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)
28 Mar 24
Press Releases
Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
29 Feb 24
Press Releases
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
23 Feb 24
Press Releases
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
15 Feb 24
Press Releases
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call
1 Feb 24
Press Releases